* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Infographic: Carbapenemase
Survey
Document related concepts
Cyanobacteria wikipedia , lookup
Neisseria meningitidis wikipedia , lookup
Clostridium difficile infection wikipedia , lookup
Small intestinal bacterial overgrowth wikipedia , lookup
Unique properties of hyperthermophilic archaea wikipedia , lookup
Trimeric autotransporter adhesin wikipedia , lookup
Quorum sensing wikipedia , lookup
Phage therapy wikipedia , lookup
Bacteriophage wikipedia , lookup
Anaerobic infection wikipedia , lookup
Human microbiota wikipedia , lookup
Carbapenem-resistant enterobacteriaceae wikipedia , lookup
Bacterial cell structure wikipedia , lookup
Transcript
Carbapenemase-producing Bacteria MULTIDRUG RESISTANCE AMONG GRAM-NEGATIVE BACTERIA HAS BEEN INCREASINGLY REPORTED IN THE LAST TEN YEARS. THE EMERGENCE OF CARBAPENEMASE-PRODUCING BACTERIA IS OF PARTICULAR CONCERN AS IT LEAVES VERY FEW THERAPEUTIC OPTIONS FOR INFECTIONS WITH THESE TYPES OF BACTERIA. 26 CARBAPENEMASE-PRODUCING GRAM-NEGATIVE ORGANISMS IDENTIFIED IN SCOTLAND IN 2014, WHICH IS THE AT THE SAME LEVEL AS 2013. 8 1 KLEBSIELLA PNEUMONIAE CARBAPENEMASE-PRODUCING CLONE OF K. PNEUMONIAE ST258 IDENTIFIED. NEW-DEHLI METALLO-BETA-LACTAMASES IDENTIFIED. THE OCCURRENCE OF THESE ISOLATES IN THE COMMUNITY IS A CONCERN. 2 INCIDENTS OF LOCAL SPREAD OF CARBAPENEMASE-PRODUCING BACTERIA MEANS THAT SCOTLAND IS NOW BEING REPORTED AS A COUNTRY WITH ‘REGIONAL SPREAD’. CARBAPENEMASE-PRODUCING BACTERIA HAVE BEEN REPORTED WORLDWIDE. INCREASING INTERCONTINENTAL TRAVEL HAS CONTRIBUTED TO THEIR SPREAD. Is. 2.2% INCREASE IN THE USE OF CARBAPENEMS BETWEEN 2012 AND 2013. THIS CONTINUES THE UPWARD TREND OBSERVED IN PREVIOUS YEARS. it is CRITICAL TO PRESERVE THE USE OF THESE ANTIBIOTICS DUE TO LACK OF NEW ANTIBACTERIALS UNDER DEVELOPMENT. INTERVENTIONS AND QUALITY IMPROVEMENT to CONTAIN Carbapenemase-producing Bacteria • REVIEW OF GUIDANCE • SCOTTISH ANTIMICROBIAL PRESCRIBING GROUP (SAPG) GUIDANCE WITH RECOMMENDATIONS FOR EMPIRICAL AND TARGETED USE OF CARBAPENEMS • RAPID IDENTIFICATION THROUGH SCREENING (TWO-STEP CLINICAL RISK ASSESSMENT) • SURVEILLANCE